Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.

Exec Edge

05 Sep 2024

By Karen Roman

Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.

The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.

Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.

“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.

Contact:

Exec Edge

Editor@executives-edge.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2465826524"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2465826524\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2465826524?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d","is_english":true,"pubTime":"2024-09-05 23:57","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2465826524","market":"us","top_or_hot":-1,"title":"Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.","media":"Exec Edge","content":"<html><body><p><img height=\"612\" src=\"https://s.yimg.com/uu/api/res/1.2/fs94hglSmggkAYEKO.PktA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d\" width=\"2170\"/></p>\n<p>By Karen Roman</p>\n<p>Biotechnology company Medera Inc. said it entered a definitive merger agreement with <a href=\"https://laohu8.com/S/KVACU\">Keen Vision Acquisition Corp.</a> (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.</p>\n<p>The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.</p>\n<p>Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.</p>\n<p>“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.</p>\n<p>Contact:</p>\n<div>\nExec Edge\n</div>\n<div>\n<p>Editor@executives-edge.com</p>\n</div>\n</body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-05 23:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html><strong>Exec Edge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Karen Roman\nBiotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial ...</p>\n\n<a href=\"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".IXIC","symbol_name":"NASDAQ Composite","start_time":0,"source_url":"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html","article_id":"2465826524","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465826524","pubTimestamp":1725551842,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. , with the combined company having an implied initial enterprise value of approximately $622.6 million.The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{".IXIC":"NASDAQ Composite","BK4588":"碎股","KVACU":"Keen Vision Acquisition Corp.","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","NDAQ":"纳斯达克OMX交易所","KVACW":"KEEN VISION ACQUISITION CORPORATION C/WTS 15/03/2028 (TO PUR ORD)","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","KVAC":"KEEN VISION ACQUISITION CORPORATION"},"translate_title":"Medera与Keen Vision Acquisition Corp合并后将在纳斯达克上市。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"KVAC":0.9,"KVACU":1,"KVACW":0.9,"NDAQ":1},"content_text":"By Karen Roman\nBiotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.\nThe transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.\nMedera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.\n“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.\nContact:\n\nExec Edge\n\n\nEditor@executives-edge.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}